Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Ehrhardt

Showing results (91-100 of 100) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 100 results.
Infection Control and Hospital Epidemiology|April 27, 2018
Microbial Preparations (Probiotics) for the Prevention of Clostridium difficile Infection in Adults and Children: An Individual Patient Data Meta-analysis of 6,851 ParticipantsBradley C Johnston, Lyubov Lytvyn, Calvin Ka-Fung Lo, et al.
American Journal of Epidemiology|April 9, 2025
Defining methodologic and other core competencies for PhD-level training in epidemiologyHailey R Banack, Laura C Rosella, Stephanie Shiau, et al.
American Journal of Epidemiology|May 21, 2026
Prenatal over-the-counter acetaminophen use and birth outcomes in the ECHO cohortKatelyn K Huff, Noya Galai, Garrett Fuselier, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 17, 2022
Transfusing Convalescent Plasma as Post-Exposure Prophylaxis Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Double-Blinded, Phase 2 Randomized, Controlled TrialShmuel Shoham, Evan M Bloch, Arturo Casadevall, et al.
Medrxiv : the Preprint Server for Health Sciences|December 21, 2021
Randomized controlled trial transfusing convalescent plasma as post-exposure prophylaxis against SARS-CoV-2 infectionShmuel Shoham, Evan M Bloch, Arturo Casadevall, et al.
Transfusion|August 3, 2023
Transfusion reactions associated with COVID-19 convalescent plasma in outpatient clinical trialsMoises A Huaman, Jay S Raval, James H Paxton, et al.
Medrxiv : the Preprint Server for Health Sciences|January 4, 2022
Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent PlasmaDavid J Sullivan, Kelly A Gebo, Shmuel Shoham, et al.
The New England Journal of Medicine|March 30, 2022
Early Outpatient Treatment for Covid-19 with Convalescent PlasmaDavid J Sullivan, Kelly A Gebo, Shmuel Shoham, et al.
JCI Insight|March 14, 2024
Outpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trialHan-Sol Park, Anna Yin, Caelan Barranta, et al.
Medrxiv : the Preprint Server for Health Sciences|May 3, 2023
Outpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trialHan-Sol Park, Anna Yin, Caelan Barranta, et al.
Pageof 10

Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
Infection Control and Hospital Epidemiology|April 27, 2018
Microbial Preparations (Probiotics) for the Prevention of Clostridium difficile Infection in Adults and Children: An Individual Patient Data Meta-analysis of 6,851 ParticipantsBradley C Johnston, Lyubov Lytvyn, Calvin Ka-Fung Lo, et al.
American Journal of Epidemiology|April 9, 2025
Defining methodologic and other core competencies for PhD-level training in epidemiologyHailey R Banack, Laura C Rosella, Stephanie Shiau, et al.
American Journal of Epidemiology|May 21, 2026
Prenatal over-the-counter acetaminophen use and birth outcomes in the ECHO cohortKatelyn K Huff, Noya Galai, Garrett Fuselier, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 17, 2022
Transfusing Convalescent Plasma as Post-Exposure Prophylaxis Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Double-Blinded, Phase 2 Randomized, Controlled TrialShmuel Shoham, Evan M Bloch, Arturo Casadevall, et al.
Medrxiv : the Preprint Server for Health Sciences|December 21, 2021
Randomized controlled trial transfusing convalescent plasma as post-exposure prophylaxis against SARS-CoV-2 infectionShmuel Shoham, Evan M Bloch, Arturo Casadevall, et al.
Transfusion|August 3, 2023
Transfusion reactions associated with COVID-19 convalescent plasma in outpatient clinical trialsMoises A Huaman, Jay S Raval, James H Paxton, et al.
Medrxiv : the Preprint Server for Health Sciences|January 4, 2022
Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent PlasmaDavid J Sullivan, Kelly A Gebo, Shmuel Shoham, et al.
The New England Journal of Medicine|March 30, 2022
Early Outpatient Treatment for Covid-19 with Convalescent PlasmaDavid J Sullivan, Kelly A Gebo, Shmuel Shoham, et al.
JCI Insight|March 14, 2024
Outpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trialHan-Sol Park, Anna Yin, Caelan Barranta, et al.
Medrxiv : the Preprint Server for Health Sciences|May 3, 2023
Outpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trialHan-Sol Park, Anna Yin, Caelan Barranta, et al.
Pageof 10